Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment

NCT01727440 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT01727440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01727440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
August 31, 2015
Enrollment
123 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris, isotretinoin